Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma - Wu, Rui-Yan; Kong, Peng-Fei; Xia, Liang-Ping; Huang, Yun; Li, Zhi-Ling; Tang, Yun-Yun; Chen, Yu-Hong; Li, Xuan; Senthilkumar, Ravichandran; Zhang, Hai-Liang; Sun, Ting; Xu, Xue-Lian; et al. (Clinical cancer research, 2019)